Literature DB >> 15008975

Somatostatin is a specific inhibitor of SDF-1alpha-induced T cell infiltration.

T Talme1, J Ivanoff, K G Sundqvist.   

Abstract

The chemokine stromal cell-derived factor 1alpha (SDF-1alpha) is a potent stimulator of T cell infiltration into three-dimensional type I collagen matrices as demonstrated using T cells freshly isolated from blood and an activated T cell clone. The neuropeptide somatostatin selectively inhibits SDF-1alpha induced T cell infiltration by the same T cells including CD4 as well as CD8 positive cells, while somatostatin does not inhibit 'spontaneous' T cell infiltration. A number of other neuropeptides and opioids do not inhibit SDF-1alpha-induced T cell infiltration, indicating that the inhibitory effect is somatostatin-specific. The neuropeptide antagonist cyclosomatostatin abrogated the inhibitory effect of somatostatin on T cell infiltration, indicating that the effect of somatostatin is mediated via specific somatostatin receptors. Somatostatin does not inhibit SDF-1alpha-induced T cell attachment to the collagen substrate, which indicates that this neuropeptide specifically inhibits the process of chemokine-induced T cell penetration and migration through the collagen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15008975      PMCID: PMC1808980          DOI: 10.1111/j.1365-2249.2003.02370.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

Review 1.  The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

Authors:  S W Lamberts; E P Krenning; J C Reubi
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

Review 2.  Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Authors:  T A Springer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

3.  Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes.

Authors:  R N Johnatty; D D Taub; S P Reeder; S M Turcovski-Corrales; D W Cottam; T J Stephenson; R C Rees
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

4.  Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts.

Authors:  D G Payan; C A Hess; E J Goetzl
Journal:  Cell Immunol       Date:  1984-04-01       Impact factor: 4.868

Review 5.  Somatostatin (second of two parts).

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

Review 6.  Lymphocyte homing and homeostasis.

Authors:  E C Butcher; L J Picker
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

7.  T lymphocyte infiltration of two- and three-dimensional collagen substrata by an adhesive mechanism.

Authors:  K G Sundqvist; D Hauzenberger; K Hultenby; S E Bergström
Journal:  Exp Cell Res       Date:  1993-05       Impact factor: 3.905

Review 8.  G proteins in lymphocyte signalling.

Authors:  D Cantrell
Journal:  Curr Opin Immunol       Date:  1994-06       Impact factor: 7.486

Review 9.  Somatostatin receptor expression in clinical immunology.

Authors:  P M van Hagen
Journal:  Metabolism       Date:  1996-08       Impact factor: 8.694

10.  Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane.

Authors:  M Xia; D Leppert; S L Hauser; S P Sreedharan; P J Nelson; A M Krensky; E J Goetzl
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

View more
  1 in total

1.  Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic rats.

Authors:  James M Dominguez; Mark A Yorek; Maria B Grant
Journal:  Diabetes       Date:  2014-09-09       Impact factor: 9.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.